Washington (AP) – An official of the Food and Drug Administration receives his job as the top vaccine regulator of the agency, less than two weeks after he has been under pressure to withdraw from President Donald Trump at the urging of Biotech executives, patient groups and conservative allies.
Dr. Vinay Prasad resembles the management of the FDA center, which regulates vaccines and biotech therapies, said a spokesman for the Ministry of Health and Human Services in a statement on Monday.
The agency left Prasad at the end of the last month after drawing the right right drive, including Laura Loomer, due to his previous statements in which Trump was criticized.
As a long -standing critic of the FDA standards for the approval of pharmaceuticals, Prasad briefly ordered the manufacturer of gene therapy for Duchenne’s muscular dystrophy to stop the programs after two deaths for patients. However, this campaign triggered the families of boys with the fatal state and libertarian followers from increased access to experimental medication.
Prasad’s decision to pause the therapy was criticized by the Wall Street Journal Editorial Board, the former Republican Senator Rick Santorum and others. The FDA quickly turned its decision to suspend the operate of the therapy.
Loomer published online that Prasad was “a progressive left saboteur” and found his story as a liberal independent Senator Bernie Sanders.
But Prasad had the support of the FDA commissioner Marty Makary and the Minister of Health Robert F. Kennedy Jr., who asked both to review the operate of covid 19 vaccines. Under Prasad, the FDA narrow the approval of two recent COVID 19 shots from Novavax and Moderna vaccination and set stricter test requirements for future permits.
___
The Department of Health and Science Department of Associated Press receives support from the Department of Science Education of the Howard Hughes Medical Institute and Robert Wood Johnson Foundation. The AP is only responsible for all content.
